Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

November 30, 2007

Conditions
Respiratory Distress SyndromeBronchopulmonary Dysplasia
Interventions
DRUG

Infasurf

Infasurf 3 cc/kg instilled via endotracheal tube, repeated 3 and 7 days later if infant stable and continues to meet criteria

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

collaborator

Women & Children's Hospital of Buffalo

OTHER

collaborator

Children's Mercy Hospital Kansas City

OTHER

collaborator

St. Louis Children's Hospital

OTHER

collaborator

UCSF Benioff Children's Hospital Oakland

OTHER

collaborator

Alta Bates Summit Medical Center

OTHER

collaborator

Long Island Jewish Medical Center

OTHER

lead

Children's Hospital of Philadelphia

OTHER

NCT00208039 - Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates | Biotech Hunter | Biotech Hunter